The prion diseases: Creutzfeldt-Jakob, Gerstmann-Sträussler-Scheinker, and related disorders

Journal of Geriatric Psychiatry and Neurology

Volumn 11, Issue 2, 1998, Pages 78-97

  Mastrianni, James A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN; PENTOSAN POLYSULFATE; PRION PROTEIN; SURAMIN;

ADULT; AGED; AMINO ACID SEQUENCE; CREUTZFELDT JAKOB DISEASE; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; MOLECULAR GENETICS; PHENOTYPE; POINT MUTATION; PRION DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DNA MUTATIONAL ANALYSIS; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; PHENOTYPE; PRION DISEASES; PRIONS; REPETITIVE SEQUENCES, AMINO ACID; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0032420150     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879801100206     Document Type: Article

References (210)

1. Cuillé J, Chelle PL. Experimental transmission of trembling to the goat. C R Seances Acad Sci 1939; 208:1058-1060.
2. Gajdusek DC, Gibbs CJ, Jr., Alpers M. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1966; 209:794-796.
3. Gibbs CJ, Jr., Gajdusek DC, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968; 161:388-389.
4. Gibbs CJ, Jr., Amyx HL, Bacote A, et al. Oral transmission of kuru, Creutzfeldt-Jakob disease and scrapie to nonhuman primates. J Infect Dis 1980; 142:205-208.
5. Chandler RL. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1961; 1:1378-1379.
6. Alper T, Haig DA, Clarke MC. The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 1966; 22:278-284.
7. Alper T, Cramp WA, Haig DA, et al. Does the agent of scrapie replicate without nucleic acid? Nature 1967; 214:764-766.
8. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-144.
9. McKinley MP, Bolton DC, Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983; 35:57-62.
10. Prusiner SB, McKinley MP, Groth DF, et al. Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA 1981; 78:6675-6679.
11. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309-1311.
12. Oesch B, Westaway D, Wälchli M, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40:735-746.
13. Safar J, Roller PP, Gajdusek DC, Gibbs CJ, Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. JBiol Chem 1993; 268:20276-20284.
14. Büeler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-582.
15. Büeler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-1347.
16. Sailer A, Büeler H, Fischer M, et al. No propagation of prions in mice devoid of PrP. Cell 1994; 77:967-968.
17. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83:79-90.
18. James TL, Liu H, Ulyanov NB, et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci USA 1997; 94:10086-10091.
19. Kaneko K, Zulianello L, Scott M, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 1997; 94:10069-10074.
20. Liao Y-C, Lebo RV, Clawson GA, Smuckler EA. Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implication. Science 1986; 233:364-367.
21. Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51:229-240.
22. Jendroska K, Heinzel FP, Tbrchia M, et al. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 1991; 41:1482-1490.
23. Kretzschmar HA, Prusiner SB, Stowring LE, DeAnnond SJ. Scrapie prion proteins are synthesized in neurons. Am J Pathol 1986; 122:1-5.
24. Bendheim PE, Brown HR, Rudelli RD, et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 1992; 42:149-156.
25. Perini F, Vidai R, Ghetti B, et al. PrP2MO is a normal soluble prion protein fragment released by human platelets. Biochem Biophys Res Commun 1996; 223:572-577.
26. Borchelt DR, Koliatsis VE, Guarnieri M, et al. Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J Biol Chem 1994; 269:14711-14714.
27. Askanas V, Sarkozi E, Bilak M, et al. Human muscle macrophages express b-amyloid precursor and prion proteins and their mRNAs. Neuroreport 1995; 6:1045-1049.
28. Westaway D, DeArmond SJ, Cayetano-Canlas J, et al. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 1994; 76:117-129.
29. Collinge J, Whittington MA, Sidle KG, et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-297.
30. Whittington MA, Sidle KCL, Gowland I, et al. Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nat Genet 1995; 9:197-201.
31. Manson JC, Hope J, Clarke AR, et al. PrP gene dosage and long term potentiation [letter]. Neurodegeneration 1995; 4:113-114.
32. Brown DR, Qin K, Herms JW, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390:684-687.
33. Stöckel J, Safar J, Wallace AC, et al. Prion protein selectively binds copper-II-ions. Biochemistry 1998; 37:7185-7193.
34. Lledo P-M, Tremblay P, DeArmond SJ, et al. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci USA 1996; 93:2403-2407.
35. Ibbler I, Gaus SE, Deboer T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380:639-642.
36. Brown P, Cathala F, Raubertas RF, et al. The epidemiology of Creutzfeldt-Jakob disease: conclusion of 15-year investigation in France and review of the world literature. Neurology 1987; 37:895-904.
37. Spudich S, Mastrianni JA, Wrensch M, et al. Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1995; 1:607-613.
38. Hsiao K, Baker HF, Crow TJ, et al. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 1989; 338:342-345.
39. Giaccone G, Tagliavini F, Verga L, et al. Neurofibrillary tangles of the Indiana kindred of Gerstmann-Straussler-Scheinker disease share antigenic determinants with those of Alzheimer disease. Brain Res 1990; 530:325-329.
40. Hsiao K, Cass C, Conneally PM, et al. Atypical GerstmannStraussler-Scheinker syndrome with neurofibrillary tangles: no mutation in the prion protein open-reading-frame in a patient of the Indiana kindred. Neurobiol Aging 1990; 11:302.
41. Giaccone G, Tagliavini F, Verga L, et al. Indiana kindred of Gerstmann-Straussler-Scheinker disease: neurofibrillary tangles and neuntes of plaques with PrP amyloid share antigenic determinants with those of Alzheimer's disease. In: Iqbal K, McLachlan D, Winblad B, et al, eds. Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies. Chichester, UK: John Wiley & Sons, 1991:207-211.
42. Ghetti B, Piccardo P, Spillantini MG, et al. Vascular variant of prion protein cerebral amyloidosis with t-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 1996; 93:744-748.
43. Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859-7868.
44. Bessen RA, Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992; 73:329-334.
45. Collinge J, Sidle KCL, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of new variant CJD. Nature 1996; 383:685-690.
46. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389:498-501.
47. Lasmézas CI, Deslys J-P, Demaimay R, et al. BSE transmission to macaques. Nature 1996; 381:743-744.
48. Collinge J, Hill AF, Sidle KCL, et al. Biochemical typing of scrapie strains [reply]. Nature 1997; 386:564.
49. Scott MR, Safar J, Telling G, et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc Natl Acad SciUSA 1997; 94:14279-14284.
50. DeArmond SJ, Sânchez H, Yehiely F, et al. Selective neuronal targeting in prion disease. Neuron 1997; 19:1337-1348.
51. Brown P, Rodgers-Johnson P, Cathala F, et al. CreutzfeldtJakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann Neurol 1984; 16:295-304.
52. Brown P, Cathala F, Castaigne P, Gajdusek DC. CreutzfeldtJakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20:597-602.
53. Chiafalo N, Fuentes AN, Galvez S. Serial EEC findings in 27 cases of Creutzfeldt-Jakob disease. Arch Neurol 1980; 37: 143-145.
54. Gomori AJ, Partnow MJ, Horoupian DS, et al. The ataxic form of Creutzfeldt-Jakob disease. Arch Neurol 1973; 29: 318-323.
55. Beck E, Daniel PM, Davey AJ, et al. The pathogenesis of transmissible spongiform encephalopathy - an ultrastructural study. Brain 1982; 105:755-786.
56. Chou SM, Payne WN, Gibbs CJ, Jr., Gajdusek DC. Transmission and scanning electron microscopy of spongiform change in Creutzfeldt-Jakob disease. Brain 1980; 103:885-904.
57. Lampert PW, Gajdusek DC, Gibbs CJ, Subacute spongiform virus encephalopathies. Scrapie, kuru and Creutzfeldt-Jakob disease: a review. Am J Pathol 1972; 68:626-652.
58. DeArmond SJ, Prusiner SB. Prion diseases. In: Lantos P, Graham D, Lantos P, Graham DS, eds. Greenfield's neuropathology, 6th edition. London: Edward Arnold, 1997:235-280.
59. Brown P, Gibbs CJ, Jr., Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35:513-529.
60. Telling GC, Scott M, Hsiao KK, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad SciUSA 1994; 91:9936-9940.
61. Anderson JR, Allen CMC, Weller RO. Creutzfeldt-Jakob disease following human pituitary-derived growth hormone administration. Br Neuropathol Sac Proc 1990; 16:543.
62. Billette de Villemeur TB, Beauvais P, Gourmelon M, Richardet JM. Creutzfeldt-Jakob disease in children treated with growth hormone [letter]. Lancet 1991; 337:864-865.
63. Billette de Villemeur T, Gelot A, Deslys JP, et al. latrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathol Appl Neurobiol 1994; 20:111-117.
64. Brown P, Gajdusek DC, Gibbs CJ, Jr., Asher DM. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985; 313:728-731.
65. Fradkin JE, Schonberger LB, Mills JL, et al. CreutzfeldtJakob disease in pituitary growth hormone recipients in the United States. JAMA 1991; 265:880-884.
66. Gibbs CJ, Jr., Asher DM, Brown PW, et al. Creutzfeldt-Jakob disease infectivity of growth hormone derived from human pituitary glands. N Engl J Med 1993; 328:358-359.
67. Brown P, Preece MA, Will RG. Friendly fire in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340:24-27.
68. Otto D. Jakob-Creutzfeldt disease associated with cadaveric dura [letter]. JNeurosurg 1987; 67:149-150.
69. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. JNeurosurg 1988; 69:766-769.
70. Nisbet TJ, MacDonaldson I, Bishara SN. Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. JAMA 1989; 261:1118.
71. Masullo C, Pocchiari M, Macchi G, et al. Transmission of Creutzfeldt-Jakob disease by durai cadaveric graft [letter, comment]. JNeurosurg 1989; 71:954-955.
72. Willison HJ, Gale AN, McLaughlin JE. Creutzfeldt-Jakob disease following cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 1991; 54:940.
73. Miyashita K, Inuzuka T, Kondo H, et al. Creutzfeldt-Jakob disease in a patient with a cadaveric durai graft. Neurology 1991; 41:940-941.
74. Sato T, Hosh K, Yoshino H, et al. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan, Janu-ary 1979-May 1996 (Reprinted from MMWR, Vol. 46, pp. 1066-1069,1997). JAMA 1998; 279(N1):11-12.
75. Dufiy P, Wolf J, Collins G, et al. Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974; 290:692-693.
76. Bernouilli C, Siegfried J, Baumgartner G, et al. Danger of accidental person to person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1:478-479.
77. Cochius JI, Mack K, Burns RJ, et al. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. AustNZJMed 1990; 20:592-593.
78. Cochius JI, Hyman N, Esiri MM. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case. J Neurol Neurosurg Psychiatry 1992; 55:1094-1095.
79. Healy DL, Evans J. Creutzfeldt-Jakob disease after pituitary gonadotrophins. BMJ 1993; 307:517-518.
80. Bateman D, Hilton D, Love S, et al. Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK [letter]. Lancet 1995; 346:1155-1156.
81. Britton TC, Al-Sarraj S, Shaw C, et al. Sporadic CreutzfeldtJakob disease in a 16-year-old in the UK [letter]. Lancet 1995; 346:1155.
82. Chazot G, Broussolle E, Lapras CI, et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man [letter]. Lancet 1996; 347:1181.
83. Kopp N, Streichenberger N, Deslys JP, et al. CreutzfeldtJakob disease in a 52-year-old woman with florid plaques [letter]. Lancet 1996; 348:1239-1240.
84. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-925.
85. Gerstmann J. Über ein noch nicht beschriebenes Reflexphanomen bei einer Erkrankung des zerebellaren Systems. Wien Med Wochenschr 1928; 78:906.
86. Gerstmann J, Sträussler E, Scheinker I. Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems zugleich ein Beitrag zur frage des vorzeitigen lokalen AI terns. Z Neurol 1936; 154:736.
87. Muramoto T, Kitamoto T, Tateishi J, Goto I. The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am J Pathol 1992; 140: 1411-1420.
88. Ghetti B, Piccardo P, Frangione B, et al. Prion protein amyloidosis (review). Brain Pathol 1996; 6:127-145.
89. Medori R, Tritschler H-J, LeBIanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992; 326:444-449.
90. Medori R, Montagna P, Tritschler HJ, et al. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 1992; 42:669-670.
91. Petersen RB, Tabaton M, Berg L, et al. Analysis of the prion protein gene in thalamic dementia. Neurology 1992; 42: 1859-1863.
92. Gambetti P, Parchi P, Petersen RB, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features [review]. Brain Pathol 1995; 5:43-51.
93. Bosque PJ, Vnencak-Jones CL, Johnson MD, et al. A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease. Neurology 1992; 42:1864-1870.
94. Reder AT, Mednick AS, Brown P, et al. Clinical and genetic studies of fatal familial insomnia. Neurology 1995; 45:1068-1075.
95. Silburn P, Cervenakova L, Varghese P, et al. Fatal familial insomnia: a seventh family, Neurology 1996; 47:1326-1328.
96. Nagayama M, Shinohara Y, Furukawa H, Kitamoto T. Fatal familial insomnia with a mutation at codon 178 of the prion protein gene: first report from Japan. Neurology 1996; 47: 1313-1316.
97. 18 F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology 1993; 43:2565-2569. j
98. Gambetti P. Fatal familial insomnia: a new human prion disease. Presented at the Prion Diseases in Humans and Animals Symposium, London, September, 1991.
99. Manetto V, Medori R, Cortelli P, et al. Fatal familial insomnia: clinical and pathological study of five new cases. Neurology 1992; 42:312-319.
100. Rancurel G, Garma L, Hauw J-J, et al. Familial thalamic degeneration with fatal insomnia: clinicopathological and polygraphic data on a French member of Lugaresi's Italian family. In: Guilleminault C, Lugaresi E, Montagna P, et al, eds. Fatal familial insomnia: inherited prion diseases, sleep, and the thalamus. New York: Raven Press, 1994:15-26.
101. McLean CA, Storey E, Gardner RJM, et al. The D178N (cis 129M) fatal familial insomnia mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology 1997; 49:552-558.
102. Parchi P, Castellani R, Cortelli P, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol 1995; 38:21-29.
103. Owen F, Poulter M, Collinge J, Crow TJ. Codon 129 changes in the prion protein gene in Caucasians. Am JHum Genet 1990; 46:1215-1216.
104. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352:340-342.
105. Windl O, Dempster M, Estibeiro JP, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996; 98:259-264.
106. Laplanche J-L, Delasnerie-Lauprêtre N, Brandel JP, et al. Molecular genetics of prion diseases in France. Neurology 1994; 44:2347-2351.
107. Salvatore M, Genuardi M, Petraroli R, et al. Polymorphisms of the prion protein gene in Italian patients with CreutzfeldtJakob disease. Hum Genet 1994; 94:375-379.
108. Deslys J-P, Marcé D, Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994; 75:23-27.
109. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767-778.
110. Parchi P, Capellari S, Chen SG, et al. Typing prion isoforms [letter]. Nature 1997; 386:232-234.
111. Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J. CJD discrepancy. Nature 1991; 353:801-802.
112. Monari L, Chen SG, Brown P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994; 91:2839-2842.
113. Laplanche J-L, Châtelain J, Launay J-M, et al. Deletion in prion protein gene in a Moroccan family. Nucleic Acids Res 1990; 18:6745.
114. Puckett C, Concannon P, Casey C, Hood L. Genomic structure of the human prion protein gene. Am J Hum Genet 1991; 49:320-329.
115. Vnencak-Jones CL, Phillips JA. Identification of heterogeneous PrP gene deletions in controls by detection of allele-specific heteroduplexes (DASH) [letter]. Am JHum Genet 1992; 50:871-872.
116. Palmer MS, Mahal SP, Campbell TA, et al. Deletions in the prion protein gene are not associated with CJD. Hum Mol Genet 1993; 2:541-544.
117. Fink JK, Peacock ML, Warren JT, et al. Detecting prion protein gene-mutations by denaturing gradient gel-electrophoresis. Hum Mutât 1994; 4:42-50.
118. Furukawa H, Kitamoto T, Tanaka Y, Tateishi J. New variant prion protein in a Japanese family with Gerstmann-Straussler syndrome. Mol Brain Res 1995; 30:385-388.
119. Goldfarb LG, Haltia M, Brown P, et al. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred [letter]. Lancet 1991; 337:425.
120. Brown P, Goldfarb LG, Kovanen J, et al. Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol 1992; 31:282-285.
121. Goldfarb LG, Brown P, Haltia M, et al. Creutzfeldt-Jakob disease (segregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol 1992; 31:274-281.
122. Nieto A, Goldfarb LG, Brown P, et al. Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families [letter]. Lancet 1991; 337:622-623.
123. Cathala F, Châtelain J, Brown P, et al. Familial CreutzfeldtJakob disease. J Neurol Sci 1980; 47:343-351.
124. Masters CL, Gajdusek DC, Gibbs CJ, The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain 1981; 104:535-558.
125. May WW, Itabashi HH, DeJong RN. Creutzfeldt-Jakob disease. Arch Neurol 1968; 19:137-149.
126. Kovanen J, Haltia M. Descriptive epidemiology of CreutzfeldtJakob disease in Finland. Acta Neurol Scand 1988; 77:474-480.
127. Haltia M, Kovanen J, Van Crevel H, et al. Familial CreutzfeldtJakob disease. J Neurol Sci 1979; 42:381-389.
128. Kitamoto T, Ohta M, Doh-ura K, et al. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 1993; 191:709-714.
129. Nitrini R, Rosemberg S, Passos-Bueno MR, et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 1997; 42:138-146.
130. Goldfarb LG, Mitrova E, Brown P, et al. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of CreutzfeldtJakob disease in Slovakia [letter]. Lancet 1990; 336:514-515.
131. Hsiao K, Meiner Z, Kahana E, et al. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl JMed 1991; 324:1091-1097.
132. Gabizon R, Rosenman H, Meiner Z, et al. Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Phil Trans R Sac Land B Biol Sci 1994; 343:385-390.
133. Goldfarb LG, Brown P, Mitrova E, et al. Creutzfeldt-Jacob disease associated with the PRNP codon 20011 mutation: an analysis of 45 families. Eur J Epidemiol 1991; 7:477-486.
134. Bertoni JM, Brown P, Goldfarb LG, et al. Familial CreutzfeldtJakob disease (codon 200 mutation) with supranuclear palsy. JAMA 1992; 268:2413-2415.
135. Inoue I, Kitamoto T, Doh-ura K, et al. Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene. Neurology 1994; 44:299-301.
136. Goldfarb L, Korczyn A, Brown P, et al. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin [letter]. Lancet 1990; 336:637-638.
137. Brown P, Gâlvez S, Goldfarb LG, et al. Familial CreutzfeldtJakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J Neurol Sci 1992; 112:65-67.
138. Goldfarb LG, Cervenâkovâ L, Brown P, et al. Genotype-phenotype correlations in familial spongiform encephalopathies associated with insert mutations. In: Court L, Dodet B, Court L, Dodet BS, eds. Transmissible subacute spongiform encephalopathies: prion diseases. Paris: Eisevier, 1996:425-431.
139. Kahana E, Zilber N, Abraham M. Do Creutzfeldt-Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 1991; 41:1390-1392.
140. Gabizon R, Kahana E, Hsiao K, et al. Inherited prion disease in Libyan Jews. In: Prusiner SB, Collinge J, Powell J, et al, eds. Prion diseases of humans and animals. London: Ellis Horwood, 1992:168-199.
141. Chapman J, Brown P, Goldfarb LG, et al. Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 1993; 56:1109-1112.
142. Neufeld MY, Josiphov J, Korczyn AD. Demyelinating peripheral neuropathy in Creutzfeldt-Jakob disease. Muscle Nerve 1992; 15:1234-1239.
143. Chapman J, Arlazoroff A, Goldfarb LG, et al. Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200' mutation. Neurology 1996; 46:758-761.
144. Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 1994; 44:1683-1686.
145. Chapman J, Brown P, Rabey JM, et al. Transmission of spongiform encephalopathies from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation. Neurology 1992; 42:1249-1250.
146. Mastrianni JA, lannicola C, Myers R, et al. Identification of a new mutation of the prion protein gene at codon 208 in a patient with Creutzfeldt-Jakob disease [abstract]. Neurology 1995; 45[Suppl]:201.
147. Pocchiari M, Salvatore M, Cutruzzola F, et al. A new point mutation of the prion protein gene in familial and sporadic cases of Creutzfeldt-Jakob disease. Ann Neurol 1993; 34: 802-807.
148. Ripoll L, Laplanche J-L, Salzmann M, et al. A new point mutation in thé prion protein gene at codon 210 in CreutzfeldtJakob disease. Neurology 1993; 43:1934-1938.
149. 148a. Shyu WC, Hsu VD, Kao MC, et al.
150. Owen F, Poulter M, Lofthouse R, et al. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease [letter]. Lancet 1989; 1:51-52.
151. Owen F, Poulter M, Shah T, et al. An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Mol Brain Res 1990; 7:273-276.
152. Crow TJ, Poulter M, Baker HF, et al. Familial dementia in relation to the 144 bp insert and its implications. In: Prusiner SB, Collinge J, Powell J, et al, eds. Prion diseases of humans and animals. London: Ellis Horwood, 1992:200-214.
153. Collinge J, Brown J, Hardy J, et al. Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 1992; 115:687-710.
154. Collinge J, Owen F, Poulter H, et al. Prion dementia without characteristic pathology. Lancet 1990; 336:7-9.
155. Poulter M, Baker HF, Frith CD, et al. Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain 1992; 115:675-685.
156. Nicholl D, Windl O, de Suva R, et al. Inherited CreutzfeldtJakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatr 1995; 58:65-69.
157. Oda T, Kitamoto T, Tateishi J, et al. Prion disease with 144 base pair insertion in a Japanese family Une. Acta Neuropathol 1995; 90:80-86.
158. Cochran EJ, Bennett DA, Cervenâkovâ L, et al. Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation. Neurology 1996; 47:727-733
159. Capellari S, Vital C, Parchi P, et al. Familial prion disease with a novel 144-bp insertion in thé prion protein gene in a Basque family. Neurology 1997; 49:133-141.
160. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:971-983.
161. Goldfarb LG, Cervenakova L, Brown P, et al. Genotype-phenotype correlations in familial spongiform encephalopathies associated with insert mutations. In: Dodet LCaB, Dodet LCaBs, eds. Transmissible subacute spongiform encephalopathies: prion diseases. Paris: Eisevier, 1996:425431.
162. Duchen LW, Poulter M, Harding AE. Dementia associated with a 216 base pair insertion in the prion protein gene. Clinical and neuropathological features. Brain 1993; 116:555-567.
163. Goldfarb LG, Brown P, McCombie WR, et al. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. ProcNatlAcad Sci USA 1991; 88:10926-10930.
164. van Gool WA, Hensels GW, Hoogerwaard EM, et al. Hypokinesia and presenile dementia in a Dutch family with a novel insertion in the prion protein gene. Brain 1995; 118:1565-1571.
165. Donne DG, Viles JH, Groth D, et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci USA 1997; 94:13452-13457.
166. Kretzschmar HA, Kufer P, Riethmüller G, et al. Prion protein mutation at codon 102 in an Italian family with GerstmannSträussler-Scheinker syndrome. Neurology 1992; 42:809-810.
167. Goldhammer Y, Gabizon R, Meiner Z, Sadeh M. An Israeli family with Gerstmann-Sträussler-Scheinker disease manifesting the codon 102 mutation in the prion protein gene. Neurology 1993; 43:2718-2719.
168. Doh-ura K, Tateishi J, Sasaki H, et al. Pro - Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 1989; 163:974-979.
169. Goldgaber D, Goldfarb LG, Brown P, et al. Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-SträusslerScheinker's syndrome. Exp Neurol 1989; 106:204-206.
170. Young K, Jones CK, Piccardo P, et al. Gerstmann-SträusslerScheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients. Neurology 1995; 45:1127-1134.
171. Kretzschmar HA, Honold G, Seitelberger F, et al. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker [letter]. Lancet 1991; 337:1160.
172. Speer MC, Goldgaber D, Goldfarb LG, et al. Support of linkage of Gerstmann-Sträussler-Scheinker syndrome to the prion protein gene on chromosome 20pl2-pter. Genomics 1991; 9:366-368.
173. Hainfelmer JA, Brantner-Inthaler S, Cervenakova L, et al. The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 1995; 5:201-211.
174. Lyketsos CG, Kraus M. The dementia of Gerstmann-Sträussler-Scheinker syndrome: clinical variability demonstrated by two case reports. J Neuropsychiatr Clin Neurosci 1995; 7:239-242.
175. Tanaka Y, Minematsu K, Moriyasu H, et al. A Japanese family with a variant of Gerstmann-Sträussler-Scheinker disease. J Neurol Neurosurg Psychiatr 1997; 62:454-457.
176. Hsiao KK, Scott M, Foster D, et al. Spontaneous neurodegencration in transgenic mice with mutant prion protein. Science 1990; 250:1587-1590.
177. Hsiao KK, Groth D, Scott M, et al. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. ProcNatlAcad Sci USA 1994;91: 9126-9130.
178. Masters CL, Gajdusek DC, Gibbs CJ, Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981; 104:559-588.
179. Amano N, Yagishita S, Yokoi S, et al. Gerstmann-SträusslerScheinker syndrome-a variant type: amyloid plaques and Alzheimer's neurofibrillary tangles in cerebral cortex. Acta Neuropathol 1992; 84:15-23.
180. Nakazato Y, Ohno R, Negishi T, et al. An autopsy case of Gerstmann-Sträussler-Scheinker's disease with spastic paraplegia as its principal feature. Clin Neurol 1991; 31:987-992.
181. Yamada M, Itoh Y, Fujigasaki H, et al. A missense mutation at codon 105 with codon 129 polymorphism of the prion protein gene in a new variant of Gerstmann-Straussler-Scheinker disease. Neurology 1993; 43:2723-2724.
182. Kitamoto T, Amano N, Terao Y, et al. A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol 1993; 34:808-813.
183. Hsiao KK, Cass C, Schellenberg GD, et al. A prion protein variant in a family with the telencephalic form of GerstmannStraussler-Scheinker syndrome. Neurology 1991; 41:681-684.
184. Mastrianni JA, Curtis MT, Oberholtzer JC, et al. Prion disease (PrP-A117V) presenting with ataxia instead of dementia. Neurology 1995; 45:2042-2050.
185. Heston LL, Lowther DLW, Leventhal CM. Alzheimer's disease: a family study. Arch Neurol 1966; 15:225-233.
186. Nochlin D, Sumi SM, Bird TD, et al. Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology 1989; 39:910-918.
187. Tateishi J, Kitamoto T, Doh-ura K, et al. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Straussler-Scheinker syndrome. Neurology 1990; 40: 1578-1581.
188. Mohr M, Tranchant C, Heldt N, et al. Alsatian variant of codon 117 form of Gerstmann-Straussler-Scheinker syndrome: autopsie study of 3 cases. Brain Pathol 1994; 4:524.
189. Hegde RS, Mastrianni JA, Scott MR, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998; 279:827-834.
190. Kitamoto T, lizuka R, Tateishi J. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 1993; 192:525-531.
191. Dlouhy SR, Hsiao K, Farlow MR, et al. Linkage of the Indiana kindred of Gerstmann-Straussler-Scheinker disease to the prion protein gene. Nat Genet 1992; 1:64-67.
192. Farlow MR, Yee RD, Dlouhy SR, et al. Gerstmann-StrausslerScheinker disease. I. Extending the clinical spectrum. Neurology 1989; 39:1446-1452.
193. Ghetti B, Tagliavini F, Masters CL, et al. Gerstmann-Straussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 1989; 39:1453-1461.
194. Ghetti B, Tagliavini F, Hsiao K, et al. Indiana variant of Gerstmann-Straussler-Scheinker disease. In: Prusiner SB, CoUinge J, Powell J, et al, eds. Prion diseases of humans and animals. London: Ellis Horwood, 1992:154-167.
195. Ghetti B, Dlouhy SR, Giaccone G, et al. Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol 1995; 5:61-75.
196. Hsiao K, Dlouhy S, Farlow MR, et al. Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1992; 1:68-71.
197. Tagliavini F, Prelli F, Porro M, et al. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 1994; 79:695-703.
198. Rosenberg RN, White LL, III, Brown P, et al. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Ann Neurol 1986; 19:75-77.
199. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. NEngl J Med 1996; 335:924-930.
200. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32-40.
201. Diringer H, Ehlers B. Chemoprophylaxis of scrapie in mice. JGen Viral 1991; 72:457-460.
202. Pocchiari M, Salvatore M, Ladogana A, et al. Experimental drug treatment of scrapie: a pathogenetic basis for rationale therapeutics. Eur J Epidemiol 1991; 7:556-561.
203. Hsiao KK, Doh-ura K, Kitamoto T, et al. A prion protein amino acid substitution in ataxic Gerstmann-Sträussler syndrome. Ann Neurol 1989; 26:137.
204. Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, et al. Two novel insertions in the prion protein gene in patients with late-onset dementia. Hum Mol Genet 1995; 4:1109-1111.204. Goldfarb LG, Brown P, Little BW, et al. A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. Neurology 1993; 43:2392-2394.
205. Campbell TA, Palmer MS, Will RG, et al. A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology 1996; 46:761-766.
206. Brown P, Goldfarb LG, McCombie WR, et al. Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology 1992; 42:422-427.
207. Mizushima S, Ishii K, Nishimaru T. A case of presenile dementia with a 168 base pair insertion in prion protein gene. Dementia 1994; 148:380-390.
208. Goldfarb LG, Brown P, Vrbovskâ A, et al. An insert mutation in the chromosome 20 amyloid precursor gene in a Gerstmann-Straussler-Scheinker family. J Neurol Sci 1992; 111:189-194.
209. Owen F, Poulter M, Collinge J, et al. A dementing illness associated with a novel insertion in the prion protein gene. Mol Brain Res 1992; 13:155-157.
210. Krasemann S, Zerr I, Weber T, et al. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Mol Brain Res 1995; 34:173-176.